Rockville Newswire

Rockville Newswire

Comprehensive Real-Time News Feed for Rockville, MD.

Results 1 - 11 of 11 for "u:drugs.com" in Rockville, MD

  1. 2006 to 2015 Saw Increase in Severe Maternal MorbidityRead the original story w/Photo

    Sep 18, 2018 | Drugs.com

    From 2006 to 2015, the proportion of women experiencing severe maternal morbidity increased 45 percent, according to a statistical brief published by the Agency for Healthcare Research and Quality. Kathryn R. Fingar, Ph.D., M.P.H., from the Agency for Healthcare Research and Quality in Rockville, Md., and colleagues presented trends and disparities in delivery hospitalizations involving severe maternal morbidity from 2006 through the third quarter of 2015.

    Comment?

  2. Advantages for HDHP Enrollees in Large Versus Small FirmsRead the original story w/Photo

    Aug 22, 2018 | Drugs.com

    Workers in small firms are more likely to have higher deductible levels and lack employer contributions to help pay for out-of-pocket expenses compared to workers in larger firms, according to a study published in the August issue of Health Affairs . G. Edward Miller, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Md., and colleagues used data from private-sector establishments for 2006 and 2016 from the Medical Expenditure Panel Survey-Insurance Component to examine trends in high-deductible health plan enrollment and heterogeneity in HDHPs by firm size.

    Comment?

  3. ACA Coverage Gains Include Workers Without InsuranceRead the original story w/Photo

    Aug 16, 2018 | Drugs.com

    After the expanded coverage provisions of the Affordable Care Act were implemented in 2014, self-employed individuals and wage earners without employer-sponsored health coverage offers had coverage gains equal to or greater than those of people not employed, according to a report published in the August issue of Health Affairs . Sandra L. Decker, from the Agency for Healthcare Research and Quality in Rockville, Md., and colleagues used data for 2010 to 2016 from the National Health Interview Survey to analyze changes in insurance status after the ACA for those not employed compared with workers, including the self-employed and wage earners with and without employer coverage offers.

    Comment?

  4. Many Americans Not Being Assessed for DepressionRead the original story w/Photo

    Aug 15, 2018 | Drugs.com

    Many Americans aged 35 and older are not being assessed for depression, according to a study recently published in the Journal of the American Board of Family Medicine . Elisabeth Kato, M.D., from the Agedncy for Healthcare Research and Quality in Rockville, Md., and colleagues used a nationally representative survey to evaluate whether adults aged 35+ were being assessed for depression by their health care providers in 2014 and 2015.

    Comment?

  5. Most Postmenopausal Bleeding Not Associated With CancerRead the original story w/Photo

    Aug 14, 2018 | Drugs.com

    Most women with postmenopausal bleeding will not be diagnosed with endometrial cancer, according to a review published online Aug. 6 in JAMA Internal Medicine . Megan A. Clarke, Ph.D., from the National Cancer Institute in Rockville, Md., and colleagues conducted a systematic literature review and meta-analysis to provide a reference of the prevalence of PMB in endometrial cancers and the risk of endometrial cancer in women with PMB.

    Comment?

  6. Two Regimens Fail to Stop Declines in I2-Cell FunctionRead the original story w/Photo

    Jul 13, 2018 | Drugs.com

    Neither glargine followed by metformin nor metformin alone halts the progressive deterioration of AZA2-cell function in youth with impaired glucose tolerance or recently-diagnosed type 2 diabetes, according to a study published online June 25 in Diabetes Care . On behalf of the RISE Consortium in Rockville, Md., Sharon L. Edelstein and colleagues randomized 91 pubertal, overweight/obese 10 to 19-year-old youths with IGT or type 2 diabetes of less than six months duration to either three months of insulin glargine followed by nine months of metformin or to 12 months of metformin alone.

    Comment?

  7. Coffee Drinking Found to Lower Risk of All-Cause MortalityRead the original story w/Photo

    Jul 3, 2018 | Drugs.com

    Increased coffee intake may be a beneficial addition to a healthy diet, according to a study published online July 2 in JAMA Internal Medicine . Erikka Loftfield, Ph.D., from the National Cancer Institute in Rockville, Md., and colleagues used baseline demographic, lifestyle, and genetic data from the U.K. Biobank cohort to estimate associations between coffee intake and mortality by genetic caffeine metabolism score.

    Comment?

  8. Few Receive All High-Priority Clinical Preventive ServicesRead the original story w/Photo

    Jun 21, 2018 | Drugs.com

    Only 8 percent of U.S. adults aged 35 years and older receive all high-priority clinical preventive services, according to a report published in the June issue of Health Affairs . Amanda Borsky, Dr.P.H., from the Agency for Healthcare Research and Quality in Rockville, Md., and colleagues examined receipt of 15 high-priority clinical preventive services among 2,186 U.S. adults aged 35 years and older.

    Comment?

  9. Synthetic Opioid Involvement in Opioid-Related Deaths UpRead the original story w/Photo

    May 1, 2018 | Drugs.com

    Synthetic opioid involvement in opioid-related overdose deaths increased significantly from 2010 to 2016, according to a research letter published in the May 1 issue of the Journal of the American Medical Association . Christopher M. Jones, Pharm.D., M.P.H., from the Substance Abuse and Mental Health Services Administration in Rockville, Md., and colleagues describe recent trends for synthetic opioid involvement in drug overdose deaths.

    Comment?

  10. Synthetic Biologics Provides Update on Development of SYN-004...Read the original story w/Photo

    Apr 22, 2018 | Drugs.com

    ROCKVILLE, Md., April 23, 2018 /PRNewswire/ -- Synthetic Biologics, Inc. , a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect a nd restore the health of patients, today announced that it has preliminary agreement from the U.S. Food & Drug Administration , on a proposed clinical trial synopsis for its planned Phase 3 clinical trial for SYN-004 . In accordance with recommendations and guidance received from the FDA, the Company expects the Phase 3 trial to include separate co-primary endpoints designed to evaluate the efficacy and safety of ribaxamase in a patient population being treated with a representative selection of intravenous beta-lactam antibiotics.

    Comment?

  11. Novo Nordisk Receives FDA Approval of Ozempic (semaglutide) Injection ...Read the original story w/Photo

    Dec 5, 2017 | Drugs.com

    December 5, 2017 -- Novo Nordisk today announced that the U.S. Food and Drug Administration approved its New Drug Application for Ozempic injection 0.5 mg or 1 mg, a once-weekly glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.1 Ozempic is administered once weekly, on the same day each week, and can be taken any time of the day, with or without meals.1 The approval of Ozempic is based on the results from a Phase 3a clinical trial program.

    Comment?

Rockville Job Listings
View or post Rockville job listings on Topix.
Rockville Real Estate
News, listings, and foreclosures in Rockville from Topix.
Rockville Mortgages
Find mortgage rates in Rockville on Topix.